Brillpharma Private Limited, a active foreign private limited company, was established on 16 April 2012 in Mumbai, Maharashtra, India. Engaging in business support services within the support service to organizations sector, it holds CIN: U24233MH2012FTC229720. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.88 M.
It upholds a compliant status. Employing 92 professional, Its leadership includes Thembalath Narayanan Kutty (Director), Priti Ramachandran Nair (Director), Ramachandran Thembalath Moothedath Ramankutty Nair (Director). Past directors included Thembalath Narayanan Kutty, Priti Ramachandran. It holds no open charges and ₹3.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 103, Hyde Park, Saki Vihar Road,Andheri (E), Mumbai, Maharashtra, 400072.
U24233MH2012FTC229720
229720
16 April 2012
₹2.50 M
₹0.88 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Brillpharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thembalath Narayanan Kutty | Director | 20 Mar 2015 | Current |
| Priti Ramachandran Nair | Director | 16 Apr 2012 | Current |
| Ramachandran Thembalath Moothedath Ramankutty Nair | Director | 16 Apr 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Brillpharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.33% increase. The company also saw a substantial improvement in profitability, with a 41.04% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Brillpharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹37,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2016 | Others | ₹3.75 Cr | Satisfied |
Explore comprehensive loan charge details -
Brillpharma has a workforce of 92 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Brillpharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brillpharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Brillpharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Brillpharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on A charge registered on 30 Sep 2016 via Charge ID 100057229 with Others was fully satisfied on 17 Mar 2022. was documented.
Progress on A charge with Others amounted to Rs. 37.50 M with Charge ID 100057229 was registered on 30 Sep 2016. was documented.
Progress on Thembalath Narayanan Kutty was appointed as a Director was appointed as a Director on 20 Mar 2015 & has been associated with this company since 10 years 10 months . was documented.
Priti Ramachandran Nair was appointed as a Director was appointed as a Director on 16 Apr 2012 & has been associated with this company since 13 years 9 months . was recorded as a recent event.
The CIN of Brillpharma Private Limited is U24233MH2012FTC229720.
Brillpharma Private Limited is headquartered at 103, Hyde Park, Saki Vihar Road,Andheri (E), Mumbai, Maharashtra, 400072.
Brillpharma Private Limited was incorporated on 16 April 2012.
The current directors of Brillpharma Private Limited are
The primary industry of Brillpharma Private Limited is Support Service To Organizations.
Brillpharma Private Limited is unlisted.
The authorized capital of Brillpharma Private Limited is ₹2.50 M, and the paid-up capital is ₹0.88 M.
The compliance status of Brillpharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX